Fundraising Fox
IntelliCyt
Acquired10,112 employees on LinkedIn · 3 known investors
Find your way into IntelliCyt
Sign up to find every way you can get introduced to IntelliCyt
- Your email: who you already know at IntelliCyt, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the IntelliCyt team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Intellicyt (now part of Sartorius) develops the iQue high-throughput screening (HTS) flow cytometry platform, which combines sampling hardware and analysis software to generate multiplexed cell phenotype and function data from 96- or 384-well plates. It serves life science researchers working in areas such as antibody discovery, T-cell engineering, and immuno-oncology.
Investors · 3
Frequently asked questions
- What does IntelliCyt do?
- Intellicyt (now part of Sartorius) develops the iQue high-throughput screening (HTS) flow cytometry platform, which combines sampling hardware and analysis software to generate multiplexed cell phenotype and function data from 96- or 384-well plates. It serves life science researchers working in areas such as antibody discovery, T-cell engineering, and immuno-oncology.
- Who are IntelliCyt's investors?
- IntelliCyt's investors include Arboretum Ventures, Prolog Ventures, Saba Investments.